Dexcom | DXCM

Stock Price
80.51
Daily Change
-0.25 -0.31%
Monthly
5.38%
Yearly
17.11%
Q3 Forecast
79.84

Peers Price Chg Day Year Date
Abbott 132.94 0.13 0.10% 16.68% Sep/05
Align Technology 139.12 4.42 3.28% -37.08% Sep/05
AtriCure 35.38 -0.28 -0.79% 34.83% Sep/05
Avanos Medical 12.72 0.06 0.47% -46.37% Sep/05
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Boston Scientific 107.22 -0.07 -0.07% 31.36% Sep/05
Cooper Companies 68.09 0.09 0.13% -36.13% Sep/05
Dexcom 80.51 -0.25 -0.31% 17.11% Sep/05
Edwards Lifesciences 80.94 -0.02 -0.02% 21.19% Sep/05
Globus Medical 60.60 0.31 0.51% -13.42% Sep/05
Hologic 66.76 0.37 0.56% -18.16% Sep/05
Integra LifeSciences 15.99 0.34 2.17% -13.57% Sep/05
J&J 178.43 -0.33 -0.18% 8.51% Sep/05
Masimo 147.19 4.18 2.92% 31.97% Sep/05
Medtronic 92.93 0.13 0.14% 3.32% Sep/05
Merit Medical Systems 92.97 0.82 0.89% -3.74% Sep/05
Insulet 348.43 1.96 0.57% 62.25% Sep/05
Roche Holding 274.20 -1.50 -0.54% 2.62% Sep/06
Solventum Corp 72.72 0.34 0.47% 9.85% Sep/05
Stryker 392.31 -2.03 -0.51% 9.17% Sep/05
Teleflex 130.70 1.61 1.25% -46.61% Sep/05
Tandem Diabetes Care 12.58 0.19 1.53% -70.33% Sep/05
West Pharmaceutical Services 250.73 3.19 1.29% -15.66% Sep/05
Zimmer Biomet Holdings 105.73 0.97 0.93% 0.76% Sep/05

Indexes Price Day Year Date
USND 21700 -7.31 -0.03% 30.01% Sep/05
US2000 2391 11.44 0.48% 14.33% Sep/05
US500 6481 -20.59 -0.32% 19.84% Sep/05
US100 23652 19.43 0.08% 28.40% Sep/05

Dexcom traded at $80.51 this Friday September 5th, decreasing $0.25 or 0.31 percent since the previous trading session. Looking back, over the last four weeks, Dexcom lost 5.38 percent. Over the last 12 months, its price rose by 17.11 percent. Looking ahead, we forecast Dexcom to be priced at 79.84 by the end of this quarter and at 77.87 in one year, according to Trading Economics global macro models projections and analysts expectations.

Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.